The raised full-year guidance and accelerating organic growth (7% vs 6% in H1) reinforce confidence in Dover's diversified industrial portfolio. Watch Q4 orders and commentary on 2027 backlog conversion — management noted a significant portion of backlog is scheduled for 2027 delivery, which could support above-algorithm growth next year.
Price Chart
Executive Summary
Dover reported Q3 2026 adjusted EPS of $2.88, a 1.2% beat vs consensus of $2.85, on revenue of $2.23B (8% YoY growth, 7% organic). The company raised its full-year 2026 adjusted EPS guidance to $10.60-$10.75 and highlighted strong bookings growth across all five segments, with particular strength in AI, energy transition, and biopharma end markets. The beat is modest but the raised guidance and accelerating organic growth support a mildly bullish read.
Key Financial Metrics
Key Facts
- Q3 2026 adjusted EPS $2.88 vs consensus $2.85 (1.2% beat)
- Revenue $2.23B, +8% YoY (+7% organic), vs consensus $2.21B
- Full-year 2026 adjusted EPS guidance raised to $10.60-$10.75 (from prior range not stated in filing)
- GAAP EPS from continuing ops $2.50, +14% YoY
- Bookings increased across all five segments and outpaced shipments
- Over $330M in share repurchases during Q3
- Two bolt-on acquisitions announced in the quarter
- Operating cash flow $438.8M in Q3, free cash flow $383.3M
Financial Impact
Adjusted EPS beat consensus by $0.03 (1.2%); revenue beat by ~$24M (1.1%). Full-year adjusted EPS guidance midpoint of $10.675 implies ~11% YoY growth vs FY2025 adjusted EPS of $9.61.
Risk Factors
- Europe organic revenue declined 3% in Q3, signaling regional weakness
- Restructuring costs of $21.8M in Q3 (vs $15.9M a year ago) indicate ongoing footprint consolidation
- Share repurchase activity ($330M+) may signal limited large M&A pipeline
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302916126 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | Institutional Cluster | $202.85 | awaiting T+1 | awaiting T+1 | $206.18 (+1.64%) |
Oct 22, 2026 5d ago | 8-K | $195.49 $199.20 | ▲ +1.90% | ▲ +2.42% | $206.18 (+5.47%) |
Oct 22, 2026 5d ago | Press Release | $195.49 $199.20 | ▲ +1.90% | ▲ +2.42% | $206.18 (+5.47%) |
Aug 18, 2026 10w ago | Press Release | $202.38 $199.88 | ▼ −1.24% | ▼ −0.40% | $206.18 (+1.88%) |
Aug 12, 2026 10w ago | Press Release | $206.66 $207.07 | ▲ +0.20% | ▲ +0.40% | $206.18 (−0.23%) |
Jul 23, 2026 13w ago | 8-K | $197.80 $202.20 | ▲ +2.22% | ▲ +2.12% | $206.18 (+4.24%) |
Apr 23, 2026 26w ago | 8-K | $228.15 $224.78 | ▼ −1.48% | ▼ −2.26% | $206.18 (−9.63%) |
Apr 8, 2026 28w ago | 8-K | $218.32 $217.12 | ▼ −0.55% | ▼ −0.49% | $206.18 (−5.56%) |
Mar 24, 2026 31w ago | DEFA14A | $215.58 $215.16 | ▼ −0.19% | ▼ −0.76% | $206.18 (−4.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers